Infectious disease screening for asylum seekers at a reception center
Official title: REACH - Responsive Evaluation and Assessment for Communicable Diseases in Migrants Hosted in Reception Centers
Run by IRCCS Sacro Cuore Don Calabria di Negrar · NCT07487506 · Data updated 2026-11-12
A one-time blood, urine, stool testing and physical exam to test for common infections in asylum seekers who have been in Italy between 2 and 36 months.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | IRCCS Sacro Cuore Don Calabria di Negrar Academic / other |
| Locations | 1 site (Negrar, Verona) |
| Status | Recruiting |
| Started | April 8, 2025 |
| Main results expected | September 8, 2026 |
| Study ends | September 8, 2026 |
| Registry record updated | March 30, 2026 |
| Trial ID | NCT07487506 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Asylum seekers aged 18 or older, residing in reception centers and present in Italy for at least 2 months but no more than 36 months, who consent to screening.
✕Probably not a fit
People under 18, those in Italy for less than 2 months or more than 36 months, and anyone who refuses consent are not eligible and will not receive the screening benefits.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center, non-profit project will estimate how common a range of infections is among adult asylum seekers hosted in reception centers. Participants will attend one visit for medical history, vital signs, physical exam, and collection of blood, urine, and stool samples. Blood tests include complete blood count, liver and kidney markers, HIV, HBV, HCV, syphilis, Quantiferon for tuberculosis, and serologies for several parasitic infections; urine and stool will be examined for parasitological findings when indicated. Results will be used to identify undiagnosed infections and to inform local clinical and public health responses.
Why it matters
Potential benefit: If successful, the screening could identify undiagnosed infections so participants can receive timely treatment and reduce onward transmission.
How similar studies have gone: Similar targeted screening programs in migrant populations have previously identified elevated rates of tuberculosis, viral hepatitis, and parasitic infections and informed follow-up care.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All asylum seekers residing in reception centers who are 18 years of age or older, have been in Italy for at least 2 months but no more than 36 months, who express their consent to undergo screening. Exclusion Criteria: * Individuals under the age of 18; Asylum seekers who have been in Italy for less than 2 months or for more than 36 months; Refusal to consent to participate in the study
Where it's running
-
IRCCS Sacro Cuore Don Calabria
Negrar, Verona, Italy Recruiting
Study contacts
- Study coordinator: Elvia Malo, Dr.
- Email: elvia.malo@sacrocuore.it
- Phone: 0456013111
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Intensive Visual Simulation before exoskeleton gait training in people with hemisensory brain injury
This study tests whether a brief IVS session before exoskeleton-assisted walking helps people with sensory- impaired stroke-related hemiparesis to walk independently.
-
Robotic upper-limb rehab vs standard therapy for adults with tetraplegia
This study tests whether a robotic arm rehabilitation device (PABLO®) plus standard therapy helps people with tetraplegia recover more upper-limb strength than standard rehab alone.
-
Duodenal organoids to study how the gut lining interacts with pathogens
Researchers are using tissue from patients who have part of their duodenum removed to grow living 3D organoids and test how the intestinal epithelium responds to pathogens in the lab.
-
Reducing treatment volume for spinal metastases using stereotactic body radiation therapy
This pilot study will try using MRI-defined tumor volumes instead of standard guideline volumes for SBRT in adults with up to five spinal metastases.
-
Female genital schistosomiasis screening for migrant women with gynecologic symptoms in Italy
This study will test whether a cervical-vaginal swab with PCR can detect female genital schistosomiasis in migrant women of childbearing age who come to a gynecology clinic.
-
Observing immune response and viral shedding in Oropouche virus infection
This study looks at how the immune system reacts and how long the Oropouche virus stays in the body of people who have tested positive for it.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.